Scholars Central

Research articlePublished 31 Mar 2022

Observational Study: Application of Therapy with Equine Serum for Patients Diagnosed with COVID-19 in Tucumán, Argentina

Authors: Chahla Rossana Elena, Medina Ruiz Luis, Miguel Enrique Ferré Contreras, Mario Raya, Natalia Herrera, Ortega Eugenia Silvana, Goroso Daniel Gustavo, Peral de Bruno María de los Ángeles

1S.I.P.R.O.S.A (Province Health System), Ministry of Health, Tucumán, Argentina, Argentina; 2Divsion of Health Management, Ministry of Health, S.I.P.R.O.S.A, Tucumán, Argentina; 3Primary Care Service Network, Ministry of Health, S.I.P.R.O.S.A, Tucumán, Argentina; 4Health Research Institute, Ministry of Health, S.I.P.R.O.S.A, Tucumán, Argentina; 5Research and Technology Centre, Mogi das Cruzes University, Sao Paulo, Brazil; 6Health Research Institute, Ministry of Health, S.I.P.R.O.S.A, Tucumán, Argentina

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Purpose: The objective of this work is to make an observational study of the usage in moderate or severe state COVID-19 patients of a new therapeutic commercial product obtained after immunization of horses: CoviFab® ELEA F(ab')2 fragmented equine immunoglobulins anti SARS-CoV2. Methods: Participant centers depend on the Public Health System of Tucumán, Argentina were recruitment. Subjects were assigned to the Moderate Patient Group (MPG) and the Severe Patient Group (SPG), classified according to WHO criteria. In total, n=84 were enrolled for this study. The subjects were divided into MPG and SPG. All participants were evaluated by physical examination and COVID-19 infection was diagnosed with positive RT-PCR. Each subject received two doses of 0.16 ml/kg, according to the subject's body weight. A generalized linear model with binomial distribution was adjusted for the number of symptoms. Data was analysed using proportion, bivariate and logistic regression. P-value was considered significant at the p<0.05 threshold.. Results: Both groups were similar in age, sex, and comorbidities. A higher proportion of patient with medical discharge was observed in MPG (91.4%) vs. SPG (55.3%) (p=0.004). MPG showed 9 times more chance of receiving medical discharge than SPG (9.33 CI=[1.65, 52.81]; p=0.012). Then, the chance to get medical discharge was independent of variables sex, age, and comorbidities. Conclusion: Treatment with Equine Serum in patients with moderate and severe disease of COVID-19 managed to slightly reduce hospitalization time. This treatment improved the clinical state to obtain medical discharge. The bivariate analysis showed 8 times more chance in MGP versus SGP to receive of medical discharge and this chance was independent of the pre-existent comorbidities.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Infectious Diseases & Therapy.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Infectious Diseases & Therapy
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Chahla Rossana Elena”
  • BylineArticles whose byline prints “Medina Ruiz Luis”
  • BylineArticles whose byline prints “Miguel Enrique Ferré Contreras”
  • BylineArticles whose byline prints “Mario Raya”
  • BylineArticles whose byline prints “Natalia Herrera”
  • BylineArticles whose byline prints “Ortega Eugenia Silvana”
  • BylineArticles whose byline prints “Goroso Daniel Gustavo”